Newsroom

Sorted by: Latest

-

RH Reports Fourth Quarter and Fiscal Year 2025 Results

CORTE MADERA, Calif.--(BUSINESS WIRE)--RH (NYSE: RH) announced that it released financial results for the fourth quarter and fiscal year 2025 ended January 31, 2026, and posted an accompanying video presentation from Gary Friedman, RH Chairman and Chief Executive Officer, highlighting the Company’s continued evolution, recent performance and outlook on the Investor Relations section of the Company’s website at ir.rh.com. As previously announced, RH leadership will host a live audio webcast at 2...
-

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported financial results for the quarter and year ended December 31, 2025, and provided a business update. Business Update Initiated Evaluation of Strategic Alternatives On March 25, 2026, the Company announced that its Board of Directors has initiated a process to evaluat...
-

Fastenal celebra sus 25 años en México

WINONA, Minnesota--(BUSINESS WIRE)--Fastenal Company (NASDAQ: FAST), líder mundial en soluciones para la cadena de suministro y distribución industrial, se enorgullece de celebrar su 25.º aniversario en México, lo que destaca un legado de crecimiento, innovación y sólidas alianzas locales. La decisión de entrar en el mercado mexicano llegó en el año 2000, y la sucursal de Apodaca comenzó oficialmente a operar a principios del año siguiente. Según Nick Groth, quien ayudó a liderar la iniciativa...
-

Ulta Beauty to Participate in Upcoming Investor Conference

BOLINGBROOK, Ill.--(BUSINESS WIRE)--Ulta Beauty to Participate in Upcoming Investor Conference...
-

AM Best Downgrades Credit Ratings of Cities and Villages Mutual Insurance Company

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has downgraded the Financial Strength Rating (FSR) to B++ (Good) from A- (Excellent) and the Long-Term Issuer Credit Rating (Long-Term ICR) to “bbb+” (Good) from “a-” (Excellent) of Cities and Villages Mutual Insurance Company (Cities and Villages) (Wauwatosa, WI). The outlook of the FSR has been revised to stable from negative, while the outlook of the Long-Term ICR is negative. The Credit Ratings (ratings) reflect Cities and Villages’ balance sheet stre...
-

TruBridge Announces Fourth Quarter and Full Year 2025 Results

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG) (“TruBridge”), a leading provider of healthcare technology solutions for rural and community hospitals, today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter Financial 2025 Highlights All comparisons are to the quarter ended December 31, 2024, unless otherwise noted. Total bookings of $19.8 million compared to $14.3 million Total revenue of $87.2 million compared to $88.1 million Re...
-

Advisory for Tuesday, April 28: Edison International to Hold Conference Call on First Quarter Financial Results

--(BUSINESS WIRE)--Edison International (NYSE: EIX) WHAT: First Quarter Financial Results   WHEN: Tuesday, April 28, 2026, 1:30-2:30 p.m. (PT)     NUMBERS: 888-673-9780 — for callers in the U.S. 312-470-0178 — for international callers   PASSCODE Edison   WEBCAST: www.edisoninvestor.com   REPLAY: In addition to the live conference call and webcast, a telephone replay will be available through May 12 at 6 p.m. (PT) at the following numbers: 800-685-6667 — for callers in the U.S. 203-369-3864 — f...
-

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 31, 2026 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 24 individuals hired by Sarepta in the first quarter of 2026. The equity awards were approved in accordance with Nasdaq Listing Rule...
-

Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates

LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunology therapies for dermatologic conditions, today reported financial results for the year ended December 31, 2025, and provided corporate updates. “Our first months as a public company have been highly productive, with strong progress across our clinical, financial, and strategic priorities,” said Bradley Burnam, Chief Executive Officer of Turn T...
-

Accelerant Completes CFO Transition

ATLANTA--(BUSINESS WIRE)--Accelerant appointed Linda S. Huber as Chief Financial Officer following the previously announced CFO transition....